A synthetic peptide for use as a blocking control in assays to test for specificity of MPZL2 antibody, Alternative Names: MPZL2 control peptide, MPZL2 antibody Blocking Peptide, Anti-MPZL2 Blocking Peptide, Myelin Protein Zero-Like 2 Blocking Peptide, EVA Blocking Peptide, EVA1 Blocking Peptide, MPZL2, MPZL-2, MPZL 2, MPZL-2 Blocking Peptide, MPZL 2 Blocking Peptide
Aufreinigung
Rabbit Anti-Tau (Ab-396) Polyclonal Antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific immunogen.
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MPZL2
(Myelin Protein Zero-Like 2 (MPZL2))
Synonyme
cb837 Peptide, eva1 Peptide, mpzl2 Peptide, wu:fb07b02 Peptide, EVA1 Peptide, EVA Peptide, Eva Peptide, Eva1 Peptide, myelin protein zero-like 2b Peptide, myelin protein zero like 2 Peptide, myelin protein zero-like 2 Peptide, mpzl2b Peptide, MPZL2 Peptide, Mpzl2 Peptide
Hintergrund
Epithelial V-like antigen (EVA) is expressed in thymus epithelium and strongly downregulated by thymocyte developmental progression. This gene is expressed in the thymus and in several epithelial structures early in embryogenesis.